🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,609 results for “AB” Clear

  1. Lofexidine hydrochloride

    BRIGHT MINDS BIOSCIENCES INC.

    Normal Healthy Volunteers Will be Treated With Lofexidine to Understand the Absolute Bioavailability and Mass Balance Recovery of the Product

    phase 1 small molecule completed

    1 trial

  2. Loncastuximab Tesirine

    ADC Therapeutics SA

    B-Cell Non-Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial

  3. Loncastuximab Tesirine and Acalabrutinib

    ADC Therapeutics SA

    Chronic Lymphocytic Leukemia

    phase 1 small molecule active

    1 trial

  4. Loncastuximab Tesirine and Durvalumab

    ADC Therapeutics SA

    Diffuse Large B-Cell Lymphoma

    phase 1 small molecule terminated

    1 trial

  5. Loncastuximab tesirine and rituximab (Lonca-R)

    ADC Therapeutics SA

    Central Nervous System Lymphoma

    phase 1 small molecule active

    1 trial

  6. Lopinavir/Ritonavir 200 mg/50 mg Film Tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Bioequivalence

    phase 1 small molecule completed

    1 trial

  7. Losmapimod 15 mg oral tablet

    Fulcrum Therapeutics

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial

  8. Lynparza 100 mg film-coated tablets, AZD2281, AZD2281, AZD2281

    AstraZeneca AB

    solid tumors

    phase 1 small molecule active

    1 trial

  9. MB02-SP

    Mabxience Research SL

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  10. MCI-186

    Tanabe Pharma

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  11. MDMA

    BRIGHT MINDS BIOSCIENCES INC.

    Metabolism

    phase 1 small molecule completed

    1 trial

  12. MGL-3196 Tablet

    Madrigal Pharmaceuticals EU Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  13. MIRROR; Multispectral and bimodal fluorescent guided surgery (FGS) of high-grade glioma for refining margin assessment: A phase 1 dose finding study using Cetuximab-IRDye800CW- combined with 5-ALA

    Disc Medicine

    Glioblastoma

    phase 1 other active

    1 trial

  14. MSB11455

    Fresenius Kabi Australia Pty Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  15. MSB11456

    Fresenius Kabi Australia Pty Limited

    Healthy

    phase 1 small molecule completed

    1 trial

  16. MT-1186

    Tanabe Pharma

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial

  17. MWN109 tablet

    Shanghai University of Traditional Chinese Medicine

    Overweight or Obesity

    phase 1 small molecule active

    1 trial

  18. MYCOPHENOLATE MOFETIL, INFLIXIMAB, Rilvegostomig, Rilvegostomig, volrustomig, CARBOPLATIN, IMFINZI 50 mg/mL concentrate for solution for infusion., Datopotamab deruxtecan, AZD7789

    AstraZeneca AB

    Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

    phase 1 small molecule active

    1 trial

  19. Macitentan 10 mg tablet, once daily.

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Microvascular Angina

    phase 1 small molecule active

    1 trial

  20. Maribavir Commercial Tablet Formulation

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  21. Marijuana

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis

    phase 1 small molecule completed

    1 trial

  22. Mass Balance Study of [14C] ABBV-932 in Healthy Male Volunteers

    AbbVie Deutschland GmbH & Co. KG

    Healthy Volunteers

    phase 1 other active

    1 trial

  23. Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184

    ViiV Healthcare Pty Ltd

    human immunodeficiency virus (HIV)

    phase 1 other active

    1 trial

  24. Meloxicam 15 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources